Drug-induced parkinsonism

被引:77
作者
Lopez-Sendon, Jose [1 ]
Mena, Maria A. [2 ]
de Yebenes, Justo G. [1 ]
机构
[1] Hosp Ramon & Cajal, Serv Neurol, CIBERNED, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, CIBERNED, E-28034 Madrid, Spain
关键词
antipsychotics; calcium channel blockers; dopamine receptor blocker; drug-induced; extrapyramidal side effects; neuroleptics; parkinsonism; CINNARIZINE-INDUCED PARKINSONISM; FLUNARIZINE-INDUCED PARKINSONISM; INDUCED EXTRAPYRAMIDAL REACTIONS; VESICULAR MONOAMINE TRANSPORTER; TARDIVE-DYSKINESIA; MOVEMENT-DISORDERS; ATYPICAL ANTIPSYCHOTICS; COGNITIVE IMPAIRMENT; ANTIDEPRESSANT DRUGS; PSYCHIATRIC-PATIENTS;
D O I
10.1517/14740338.2013.787065
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Drug-induced parkinsonism (DIP) is the second most common cause of parkinsonism after idiopathic Parkinson's disease (iPD). Initially reported as a complication of antipsychotics, it was later recognized as a common complication of antidepressants, calcium channel antagonists, gastrointestinal prokinetics, antiepileptic drugs and many other compounds. Despite being a major health problem in certain populations, it seems to be frequently overlooked by the medical community. Areas covered: This paper approaches the concept of DIP, reviews its epidemiology, clinical features and ancillary tests recommended for a correct diagnosis. The authors discuss the different drugs and its pathogenic mechanisms. The relevance of an early recognition and recommendations for a correct management are commented. Expert opinion: Prescribers need to remain vigilant for DIP, particularly in the elderly, patients taking multiple drugs and those with genetic risk factors involved in iPD. Cessation of the causing agent is the main treatment and there is no evidence of benefit for the use of anticholinergics or levodopa. If the medication cannot be withdrawn, it should be switched to agents with a lower risk of DIP.
引用
收藏
页码:487 / 496
页数:10
相关论文
共 127 条
[1]   Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats [J].
Ahlenius, S ;
Ericson, E .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (04) :415-430
[2]   PRELIMINARY OBSERVATIONS ON THE PSYCHIATRIC USES OF CHLORPROMAZINE (LARGACTIL) [J].
ANTONSTEPHENS, D .
JOURNAL OF MENTAL SCIENCE, 1954, 100 (419) :543-557
[3]   Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran [J].
Arai, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01) :137-138
[4]   CALCIUM-ANTAGONIST FLUNARIZINE HYDROCHLORIDE AFFECTS STRIATAL D2 DOPAMINE-RECEPTORS IN THE YOUNG-ADULT AND AGED RAT-BRAIN [J].
ASANUMA, M ;
OGAWA, N ;
HABA, K ;
HIRATA, H ;
MORI, A .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1991, 13 (03) :271-278
[5]   A SURVEY OF DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS [J].
AYD, FJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 175 (12) :1054-&
[6]  
Baquero M, 1995, Rev Neurol, V23, P964
[7]   Parkinsonism and Parkinson's disease in the elderly: A community-based survey in Brazil (the Bambui study) [J].
Barbosa, Maira Tonidandel ;
Caramelli, Paulo ;
Palma Maia, Debora ;
Quintao Cunningham, Mauro Cesar ;
Leonardo Guerra, Henrique ;
Lima-Costa, Maria Fernanda ;
Cardoso, Francisco .
MOVEMENT DISORDERS, 2006, 21 (06) :800-808
[8]  
BATEMAN DN, 1986, Q J MED, V59, P549
[9]  
Benazzi F, 1997, INT J GERIATR PSYCH, V12, P132, DOI 10.1002/(SICI)1099-1166(199701)12:1<132::AID-GPS538>3.0.CO
[10]  
2-O